Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.

Ablacon, Inc. Raises $21.5M Series A To Advance Ai-enabled Atrial Fibrillation Mapping System

by posted 11months ago 26 views
MENLO PARK, Calif., April 30, 2019-- Ablacon, Inc. (, a Wheat Ridge, CO-based company developing an advanced mapping system to guide the treatment of atrial fibrillation (AFib), today announced the closing of a $21.5 million Series A financing round led by Ajax Health. Ablacon's novel algorithm uses artificial intelligence (AI) to analyze and visualize the flow of action potentials, or Electrographic Flow, within the heart in order to identify sources and drivers of AFib, the most common cardiac arrhythmia worldwide. The map of the Electrographic Flow can help to guide physicians in targeted catheter ablation therapy.

In this article